PfizerAstellas Tout Encouraging Data From Keytruda Combo Regime In Urothelial Cancer Showing 49 percent Reduction In Death Risk Vs. Chemo
| LSPAX Fund | USD 5.53 0.05 0.91% |
Slightly above 50% of Locorr Spectrum's investors are presently thinking to get in. The analysis of overall sentiment of trading Locorr Spectrum Income mutual fund suggests that some investors are interested at this time. Locorr Spectrum's investing sentiment can be driven by a variety of factors including economic data, Locorr Spectrum's earnings reports, geopolitical events, and overall market trends.
Locorr |
Pfizer and Astellas Padcev-Keytruda combo showed durable survival benefits in urothelial cancer, with a higher response rate and no new safety concerns.
Read at benzinga.com
 |
Locorr Spectrum Fundamental Analysis
We analyze Locorr Spectrum's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Locorr Spectrum using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Locorr Spectrum based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Last Dividend Paid
Last Dividend Paid Comparative Analysis
Locorr Spectrum is currently under evaluation in last dividend paid among similar funds. Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
Locorr Spectrum Income Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Locorr Spectrum mutual fund to make a market-neutral strategy. Peer analysis of Locorr Spectrum could also be used in its relative valuation, which is a method of valuing Locorr Spectrum by comparing valuation metrics with similar companies.
Peers
Locorr Spectrum Related Equities
| SCFFX | Shenkman Short | 0.10 | ||||
| LSYFX | Lord Abbett | 0.10 | ||||
| DNHYX | Dunham High | 0.11 | ||||
| MRHYX | Msift High | 0.12 | ||||
| JDHYX | Janus High | 0.13 | ||||
| PBHAX | Prudential High | 0.21 | ||||
| CRDOX | Six Circles | 0.66 |
Other Information on Investing in Locorr Mutual Fund
Locorr Spectrum financial ratios help investors to determine whether Locorr Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Locorr with respect to the benefits of owning Locorr Spectrum security.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |